Rockefeller Capital Management L.P.

Position in NVAX — Novavax Inc

CIK 1739439 NEW YORK, NY

Position in NVAX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$39,666

-$6,185 QoQ

Shares Held

4,211

-25.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#179

of 263 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 83% Shared 0% None 17%

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $307,135,875 across 241 Biotechnology names. NVAX ranks #109 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	149,476	$74,249,211
2	JAZZ	Jazz Pharmaceuticals plc	167,409	$40,340,545
3	ACAD	Acadia Pharmaceuticals Inc	1,015,420	$25,690,124
4	BMRN	Biomarin Pharmaceutical Inc	433,376	$24,797,774
5	PTCT	Ptc Therapeutics, Inc.	302,393	$24,666,195
6	MDGL	Madrigal Pharmaceuticals, Inc.	29,015	$15,579,603
7	REGN	Regeneron Pharmaceuticals, Inc.	21,563	$13,445,391
8	CORT	Corcept Therapeutics Inc	123,388	$10,728,585

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$39,666	4,211	-25.2%	Shares	Defined	2026-08-13
2026-03-31	$45,851	5,633	+58.5%	Shares	Defined	2026-05-14
2025-12-31	$23,888	3,555	+24.3%	Shares	Defined	2026-03-17
2025-09-30	$24,804	2,861	+114.6%	Shares	Defined	2025-11-14
2022-12-31	$13,703	1,333	0.0%	Shares	Defined	2023-03-06
2022-09-30	$24,260	1,333	-15.4%	Shares	Defined	2022-11-02
2022-06-30	$81,053	1,576	+369.0%	Shares	Defined	2022-08-12
2022-03-31	$24,746	336	-13.0%	Shares	Defined	2022-05-13
2021-12-31	$55,225	386	+62.9%	Shares	Defined	2022-02-14
2021-09-30	$49,132	237	-0.8%	Shares	Defined	2021-11-12
2021-06-30	$50,742	239	+1.3%	Shares	Defined	2021-08-10
2021-03-31	$42,789	236	+13.5%	Shares	Defined	2021-05-11
2020-12-31	$23,194	208	-11.5%	Shares	Defined	2021-02-12
2020-03-31	$3,191	235	—	Shares	Defined	2020-05-12
No filing history on record for this holder in this stock.